Skip to main content

Thyroid Cancer News (Page 2)

Related terms: Anaplastic thyroid cancer

FDA Approves Nexavar to Treat Metastatic Differentiated Thyroid Cancer

November 22, 2013 – The U.S. Food and Drug Administration today expanded the approved uses of Nexavar (sorafenib) to treat late-stage (metastatic) differentiated thyroid cancer. Thyroid cancer is...

FDA Approves Cometriq (cabozantinib) to Treat Rare Type of Thyroid Cancer

November 29, 2012 – The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasized). ...

FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid Cancer

WILMINGTON, Del.--(BUSINESS WIRE)--Apr 6, 2011 - AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Thyroid Disease

Related drug support groups

Armour Thyroid, Nature-Throid